My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    1.

    Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation.

    Basu S, Larsson A, Vessby J, Vessby B, Berne C.

    Diabetes Care. 2005 Jun;28(6):1371-5.PMID: 15920054 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population.

    Helmersson J, Vessby B, Larsson A, Basu S.

    Circulation. 2004 Apr 13;109(14):1729-34. Epub 2004 Mar 22.PMID: 15037525 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men.

    Helmersson J, Larsson A, Vessby B, Basu S.

    Atherosclerosis. 2005 Jul;181(1):201-7. Epub 2005 Apr 26.PMID: 15939073 [PubMed - indexed for MEDLINE]Related articles

    4.

    Both cyclooxygenase- and cytokine-mediated inflammation are associated with carotid intima-media thickness.

    Wohlin M, Helmersson J, Sundström J, Arnlöv J, Vessby B, Larsson A, Andrén B, Lind L, Basu S.

    Cytokine. 2007 Jun;38(3):130-6. Epub 2007 Jul 17.PMID: 17644349 [PubMed - indexed for MEDLINE]Related articles

    5.

    Glycaemic status in relation to oxidative stress and inflammation in well-controlled type 2 diabetes subjects.

    Rytter E, Vessby B, Asgård R, Johansson C, Sjödin A, Abramsson-Zetterberg L, Möller L, Basu S.

    Br J Nutr. 2009 May;101(10):1423-6.PMID: 19459227 [PubMed - indexed for MEDLINE]Related articles

    6.

    Inflammation and endothelial activation is evident at birth in offspring of mothers with type 1 diabetes.

    Nelson SM, Sattar N, Freeman DJ, Walker JD, Lindsay RS.

    Diabetes. 2007 Nov;56(11):2697-704. Epub 2007 Aug 17.PMID: 17704300 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.

    Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, Itoshima T, Makino H.

    Diabetes Care. 2005 Dec;28(12):2890-5.PMID: 16306550 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases.

    Basu S, Whiteman M, Mattey DL, Halliwell B.

    Ann Rheum Dis. 2001 Jun;60(6):627-31.PMID: 11350853 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort.

    Jenkins AJ, Rothen M, Klein RL, Moller K, Eldridge L, Zheng D, Durazo-Arvizu R, McGee D, Lackland D, Thorpe SR, Garvey WT, Lyons TJ; DCCT/EDIC Research Group.

    J Diabetes Complications. 2008 May-Jun;22(3):153-63. Epub 2008 Apr 16.PMID: 18413218 [PubMed - indexed for MEDLINE]Related articles

    10.

    Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus.

    Navarro JF, Mora C, Maca M, Garca J.

    Am J Kidney Dis. 2003 Jul;42(1):53-61.PMID: 12830456 [PubMed - indexed for MEDLINE]Related articles

    11.

    Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study.

    Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study.

    Diabetes Care. 2003 Jul;26(7):2165-73.PMID: 12832330 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Acute-phase proteins among patients with type 1 diabetes.

    Gomes MB, Piccirillo LJ, Nogueira VG, Matos HJ.

    Diabetes Metab. 2003 Sep;29(4 Pt 1):405-11.PMID: 14526268 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes.

    Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, Jialal I.

    Diabetes. 2006 Mar;55(3):774-9.PMID: 16505242 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes.

    Jenkins AJ, Zhang SX, Rowley KG, Karschimkus CS, Nelson CL, Chung JS, O'Neal DN, Januszewski AS, Croft KD, Mori TA, Dragicevic G, Harper CA, Best JD, Lyons TJ, Ma JX.

    Diabet Med. 2007 Dec;24(12):1345-51. Epub 2007 Oct 29.PMID: 17971181 [PubMed - indexed for MEDLINE]Related articles

    15.

    F2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control.

    Flores L, Rodela S, Abian J, Clària J, Esmatjes E.

    Metabolism. 2004 Sep;53(9):1118-20.PMID: 15334370 [PubMed - indexed for MEDLINE]Related articles

    16.

    Serum selenium predicts levels of F2-isoprostanes and prostaglandin F2alpha in a 27 year follow-up study of Swedish men.

    Helmersson J, Arnlöv J, Vessby B, Larsson A, Alfthan G, Basu S.

    Free Radic Res. 2005 Jul;39(7):763-70.PMID: 16036356 [PubMed - indexed for MEDLINE]Related articles

    17.

    Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.

    Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G.

    Diabet Med. 2005 Aug;22(8):999-1004.PMID: 16026364 [PubMed - indexed for MEDLINE]Related articles

    18.

    Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes.

    Dalla Vestra M, Mussap M, Gallina P, Bruseghin M, Cernigoi AM, Saller A, Plebani M, Fioretto P.

    J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S78-82.PMID: 15938041 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes.

    Schölin A, Siegbahn A, Lind L, Berne C, Sundkvist G, Björk E, Karlsson FA; Diabetes Incidence Study in Sweden group.

    Diabetes Metab Res Rev. 2004 May-Jun;20(3):205-10.PMID: 15133751 [PubMed - indexed for MEDLINE]Related articles

    20.

    Intra-day variation of in vivo prostaglandin F2alpha formation in healthy subjects.

    Helmersson J, Basu S.

    Prostaglandins Other Lipid Mediat. 2006 Jul;80(1-2):93-9. Epub 2006 Jun 19.PMID: 16846790 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity